LB Pharmaceuticals(LBRX)
NEW YORK, NYPharmaceutical
Focus: LB Pharmaceuticals is a publicly traded specialty pharmaceutical company headquartered in New York, focused on developing treatments for schizophrenia and other neuropsychiatric disorders.
Profile data last refreshed 5h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
3
Should You Work at LB Pharmaceuticals?
AI assessmentLB Pharmaceuticals offers meaningful work in neurology but presents moderate financial risk; suit candidates seeking early-stage exposure in a capital-constrained, single-asset-focused company.
Why Work Here
- Focused pipeline with LB-102 advancing through Phase 1, 2, and 3 trials for schizophrenia, a large unmet market with significant clinical impact potential.
Data completeness
3/9 — Basic
Company HealthStrong
Pipeline
Mid-stage
2 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
LB-102
SchizophreniaClinical Trials (1)
NCT04588129Receptor Occupancy of LB-102 Using Positron Emission Tomography (PET) in Healthy Volunteers
Phase 1Help build intelligence for LB Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.